Cargando…
Targeting mutant p53 for cancer therapy
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4931821/ https://www.ncbi.nlm.nih.gov/pubmed/27347904 http://dx.doi.org/10.18632/aging.100992 |
_version_ | 1782440965381816320 |
---|---|
author | Oren, Moshe Tal, Perry Rotter, Varda |
author_facet | Oren, Moshe Tal, Perry Rotter, Varda |
author_sort | Oren, Moshe |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-4931821 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Impact Journals LLC |
record_format | MEDLINE/PubMed |
spelling | pubmed-49318212016-07-18 Targeting mutant p53 for cancer therapy Oren, Moshe Tal, Perry Rotter, Varda Aging (Albany NY) Editorial Impact Journals LLC 2016-06-26 /pmc/articles/PMC4931821/ /pubmed/27347904 http://dx.doi.org/10.18632/aging.100992 Text en Copyright: © 2016 Oren et al. http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Editorial Oren, Moshe Tal, Perry Rotter, Varda Targeting mutant p53 for cancer therapy |
title | Targeting mutant p53 for cancer therapy |
title_full | Targeting mutant p53 for cancer therapy |
title_fullStr | Targeting mutant p53 for cancer therapy |
title_full_unstemmed | Targeting mutant p53 for cancer therapy |
title_short | Targeting mutant p53 for cancer therapy |
title_sort | targeting mutant p53 for cancer therapy |
topic | Editorial |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4931821/ https://www.ncbi.nlm.nih.gov/pubmed/27347904 http://dx.doi.org/10.18632/aging.100992 |
work_keys_str_mv | AT orenmoshe targetingmutantp53forcancertherapy AT talperry targetingmutantp53forcancertherapy AT rottervarda targetingmutantp53forcancertherapy |